AIBT is reshaping decentralized clinical trials. AI is responsible for accelerating subject screening and predicting drug responses, while blockchain manages informed consent through smart contracts and ensures data integrity. This allows patients to participate in trials from home while guaranteeing the authenticity of research data and the transparency of cross-border drug reviews. $AIBT #AIBT